Patent ID: 11913051
Assignee: LIMMATECH BIOLOGICS AG
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 7:
8. The host cell of claim 2, wherein a Leishmania signal and/or retention sequence is added to the N-acetyl glucosamine transferase, galactosyltransferase, and/or sialyltransferase, wherein the signal sequence is capable of targeting the N-acetyl glucosamine transferase, galactosyltransferase, and/or sialyltransferase to the endoplasmic reticulum of the Leishmania host cell, and wherein the retention sequence is capable of retaining the N-acetyl glucosamine transferase, galactosyltransferase, and/or sialyltransferase in the Golgi apparatus.